Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS - Concepedia

Concepedia

Publication | Closed Access

Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS

540

Citations

17

References

2017

Year

Zhan Yao, Rona Yaeger, Vanessa Rodrik-Outmezguine, Anthony Tao, Neilawattie M. Torres, Matthew T. Chang, Matthias Drosten, HuiYong Zhao, Todd Hembrough, Judith Michels,

OncologyActivated RasClass 3Oncogenic AgentMedicinePathologyBreast CancerBraf MutantsTumor SuppressorCancer GeneticsCancer BiologyCell BiologyCancer ResearchTumor BiologyCancer Growth

References

	Year	Citations

Page 1

Page 1